PET with [18F]Flumazenil As an Index of Neurodegeneration in MS
Clinical trial NCT03825601 · COMPLETED
Trial details
- NCT number
- NCT03825601
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-02
- Primary completion
- 2024-08-26
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.